Radiology & Cancer Research

Biography

Dr. Vermorken served on the medical staff of oncology, at the University Hospital Vrije Universiteit in Amsterdam, The Netherlands, and is Emeritus Professor of Oncology at the University of Antwerp and past head of the Department of Medical Oncology at the Antwerp University Hospital in Edegem, Belgium, where he still works as a consultant. Dr. Vermorken was principal investigator of the OncoVAX 8701 Phase IIIa clinical trial. Dr. Vermorken’s main field of interest is in gynecological oncology, and head and neck oncology. In addition, he coordinated large clinical trials in breast and colon cancer, including the OncoVAX’s Phase III trial (8701). His main research areas concern early clinical and pharmacological studies with new drugs, studies on the interaction of chemotherapy and radiation therapy, HPV in various malignancies and immunological approaches. Dr. Vermorken is a member of the European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group (GCG) and the EORTC Head and Neck Cancer Group (HNCG). He chaired the EORTC-GCG from 1983 to 1989 and the EORTC-HNCG from 2006 to 2009. He is still an active member with both groups.

Research Interest

Oncology,Head and Neck Cancer,